TNF-inhibitor drugs may reduce risk of congestive heart failure in people with rheumatoid arthritis

Not only does treatment with tumor necrosis factor (TNF) inhibitor biologic drugs not increase the risk of congestive heart failure in people with rheumatoid arthritis, but it may decrease the incidence of this serious cardiovascular disease in these patients, according to new research.

Leave a Reply

Your email address will not be published. Required fields are marked *